OCX OncoCyte Corp.

4.810.02 (+0.42%)
15 minute delayed price: 9:58:37 AM

Quote

Previous Close
$4.79
Day Range
$4.77-$4.89
52 Week Range
$1.16-$6.92
Volume
8,355
Avg Volume
193,241
Dividend TTM
-
Ex-Dividend Date
-

Valuation

Market Cap
$249.99M
Enterprise Value (EV)
$250.00M
PE Ratio
-
EV/EBITDA
-17.83
Price/Sales
-
Price/Book
72.73
PEG Ratio
0.37

Financials

Revenue
-
Gross Profit
-$559.00K
EBITDA
-$14.02M
EPS, ttm
-$0.38
Profit Margin
-
Revenue/Employee
-
Next Earnings Date
8/12/2019 (80 days)
Debt to Equity
50%
Debt
$8.48M
Cash
$8.46M
Net Debt
$13.49K

Performance

Beta
0.74
200 Day Moving Avg
$2.85
50 Day Moving Avg
$4.25
52 Week Change
99.58%
YTD Change
226.27%
1 Month Change
8.62%
3 Month Change
38.04%
6 Month Change
188.55%
1 Year Change
99.58%
2 Year Change
-25.21%
5 Year Change
-44.93%

Share Count

Shares Outstanding
52.0M
Float
29.2M
Restricted Shares
22.7M
Restricted Shares, %
43.74%

OncoCyte Corp. Company Details

Sector: Health Technology

Industry: Medical Specialties

CEO: William Annett

Website: http://www.oncocyte.com

Description: OncoCyte Corp. is a pharmaceutical company. It is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company was founded in September 2009 and is headquartered in Alameda, CA.

Employees: 12